Power supply monitoring for an implantable device

• US 7,769,455 B2
• Filed: 01/27/2006
• Issued: 08/03/2010
• Est. Priority Date: 01/27/2006
• Status: Expired due to Fees

• Current Assignee: LivaNova USA, Inc. (LivaNova Plc)
• Original Assignee: Cyberonics, Inc
• Inventors: Scott, Timothy, Inman, Dana Michael, Armstrong, Randolph, Armstrong, Scott A.
• Primary Examiner(s): Bockelman; Mark W
• Assistant Examiner(s): Dinga; Roland
• Application Number:
  US11/341,978
• Publication Number:
  US 20070179547A1
• Time in Patent Office: 1,649 Days
• Field of Search: 607/5, 607/27, 607/29, 320/132, 340/636.15, 702/63
• US Class Current: 607/29
• CPC Class Codes: A61N 1/3708 for power depletion
• CPC Class Codes: A61N 1/378 Electrical supply

Abstract

A method and an apparatus for projecting an end of service (EOS) and/or an elective replacement indication (ERI) of a component in an implantable device is provided. The method comprises measuring the measured voltage of the energy storage device, and determining whether the measured voltage is less than a transition voltage. When the measured voltage is less than the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the measured voltage. When the measured voltage is greater than or equal to the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the total charge depleted. The transition voltage is a voltage associated with the transition point of non-linearity in the battery voltage depletion curve.

Claims

1. An implantable medical device, comprising:

an energy storage device that provides power for an operation performed by the implantable medical device, characterized by a non-linear battery voltage depletion curve of voltage over time;

a stimulation unit operatively coupled to the energy storage device that provides an electrical signal; and

a controller operatively coupled to the stimulation unit and the energy storage device, the controller comprising;

a charge depletion determination unit that determines an electrical charge depleted by the energy storage device during operation of the implantable medical device;

a voltage determination unit that determines whether a measured voltage across the energy storage device has reached a transition voltage; and

a useful life determination unit that determines a time period remaining in the energy storage device'"'"'s useful life based upon at least one of

     1) a function of the electrical charge depleted, and

     2) a function of the measured voltage;

wherein the useful life determination unit determines the time period remaining in the energy storage device'"'"'s useful life based on the function of the electrical charge depleted when a measured voltage across the energy storage device is greater than or equal to the transition voltage, and the useful life determination unit determines the time period until the end of service of the energy storage device based on the function of the measured voltage when the measured voltage across the energy storage device is less than the transition voltage;

wherein when the measured voltage is less than the transition voltage, the useful life determination unit calculates the time period remaining the energy storage device'"'"'s useful life based upon the measured voltage, an end-of-service voltage, a percentage of energy storage device capacity remaining at a transition point of non-linearity in a battery voltage depletion curve representing the voltage across the energy storage device over time and at least one of the transition voltage, the total available electrical charge, and a consumption rate.

2. The implantable device of claim 1, wherein the transition voltage is a voltage associated with a transition point of non-linearity in the battery voltage depletion curve.

3. The implantable device of claim 2, wherein the transition voltage comprises a variable value based upon a consumption rate.

4. The implantable device of claim 1, wherein when the measured voltage is greater than or equal to the transition voltage, the determination unit calculates a time period remaining in the energy storage device'"'"'s useful life based upon the total charge depleted, and at least one of the total available electrical charge and a consumption rate.

7. The implantable medical device of claim 1, further comprising a correction factor unit for adding at least one of (1) a first correction factor when the measured voltage is greater than or equal to a predetermined voltage, (2) a second correction factor associated with the energy storage device impedance, and 3) a third correction factor associated with a measured temperature of the energy storage device.

5. The implantable medical device of 1, wherein the controller generates at least one of (1) an end of service signal based upon a determination that the time period remaining in the energy storage device'"'"'s useful life has already ended and (2) an elective replacement indicator signal based upon a determination that the time period remaining in the energy storage device'"'"'s useful life is less than or equal to a predetermined period of time.

6. The implantable medical device of claim 5, wherein the predetermined period of time is approximately six months.